[1]
A. Ismaila, “Cost-effectiveness of dutasteride-tamsulosin combination therapy for the treatment of symptomatic benign prostatic hyperplasia: A Canadian model based on the CombAT trial”, CUAJ, vol. 7, no. 5-6, pp. e393–401, Jun. 2013.